330 people who took part in the survey were presented with a list of management and leadership skills. Those of the respondents who are leaders were asked to rate their confidence in applying the skills, whilst those in non-management positions were asked to rate their line manager's skills. Both sets of respondents were also asked to place the skills in priority order.
The management skills were: Setting clear tasks and objectives. Providing clear roles and responsibilities. Communicating clearly and effectively. Monitoring and evaluating. Planning and organising. Effectively managing difficult situations.
The leadership skills were: Providing rationale and explaining why. Regularly providing and seeking feedback. Building trust. Providing guidance and training. Creating development plans and opportunities.
Interestingly, the survey found a close correlation between how the leaders and the employees prioritise these things, with management skills being perceived as more important overall than leadership skills.
Communicating clearly and effectively was deemed the most important skill of all (ranked 9 out of 10 by both groups). Meanwhile, creating development plans and opportunities for others was prioritised the least (ranked 3.7/10).
But hang on a moment. If both the managers and the employees agree that creating development plans and opportunities is the least important thing, then surely it is? In other words, if employees say that creating development plans is unimportant, then surely it is unimportant, and if leaders think the same, they would appear to be right.
Maybe, maybe not. Perhaps employees don't know what's good for them, and leaders don't know what employees don't know what is good for them. If you take my point.
Veterinary leaders were then asked to rate their confidence in applying the listed leadership and management skills. The skills which elicited the largest number of 'not confident' responses were: monitoring and evaluating performance, regularly providing and seeking feedback, and creating development plans and opportunities for others.
The skills with which leaders were most confident were: communicating clearly and effectively, building trust, and providing rationale and explaining why.
Again, there was a close correlation between prioritisation of these skills and confidence levels.
VMG Vice President Richard Casey said: “The survey has helped us to identify priorities for learning and development both at our 2020 Congress and during our joint CPD programme next year. It is striking that the very skills required to motivate colleagues to remain in veterinary medicine and to support them in doing so are the ones which so many veterinary leaders admit that they lack confidence. Given the challenges the profession faces, it is also concerning that they appear to be undervalued both by veterinary leaders and the team members who report to them.
"Delegates to SPVS-VMG Congress and our other 2020 CPD events will benefit from a wealth of evidence-based lectures from experts on all aspects of veterinary leadership and management, enabling them to improve their own performance and contribute to an overall raising of standards of leadership and management across the veterinary sector."
Peter Brown, Senior Vice-President of SPVS, said: "We know that veterinary students receive an excellent clinical training and, in recent years, universities have started to include more non-clinical skills on the curriculum. However, these results suggest that when professionals move into more senior roles, be it leading a team or running their own practice, they find they still need to acquire new skills. SPVS’ role has always been to equip veterinary professionals to be effective leaders and SPVS-VMG congress is an excellent opportunity to both hear inspiring speakers and meet and learn from fellow leaders within the profession."
The VMG-SPVS 2020 joint Congress takes place from 23-25 January at the Celtic Manor Resort, Newport, and will feature dedicated streams on effective leadership, management mastery, practice profitability, preparing for a digital future and sustainability in practice.
Details on the VMG-SPVS 2020 CPD Programme can be found here: https://spvs-vmg-events.co.uk/cpd-events/
The poster was put together by a team of 55 specialists and general practitioners led by Fergus Allerton.
It includes an outline of the new European Medicines Agency advice on categorising antibiotics, a new section on wounds and surgical site infections, updated advice on life-threatening infections and identifying/treating sepsis, and more advice for owners.
Fergus said: “The latest iteration of the PROTECT ME poster incorporates updated information and offers recommendations to support vets to optimise their antibiotic use.
"I hope this will be a valuable resource for vets in practice.”
The new posters will be distributed with Companion in December.
Free printable posters are available from: www.bsavalibrary.com/protectme
Printed copies can be purchased from the BSAVA store: www.bsava.com/store.
BSAVA members are also able to request free printed copies.
The company says AI Masses will allow veterinary professionals to analyse lesions suggestive of cancer in-clinic and with a fast turnaround.
The AI technology, which has been trained by human clinical pathologists, should enable individualised treatment outcomes earlier for more cases.
Zoetis says AI Masses only needs a single round of sample preparation and the results can, at additional cost, be supplemented with an expert review from a network of specialists through Zoetis’ Virtual Laboratory.
Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA, Global Chief Medical Officer at Zoetis said: “Waiting for results can be stressful for pet owners – even more so when it involves a cancer screening.
"Our research shows that up to 75% of pet owners find abnormal results highly stressful.1
"AI Masses is yet another point-of-care capability to deliver results in-clinic, further exemplifies Zoetis’ purpose to advance care for animals, shortening anxious wait times to allow for faster care decisions that help provide the best possible outcome.”
Pre-orders will be announced for US customers in Q2 2025.
VetSurgeon.org understands AI Masses will be coming to the UK some time in 2025.
https://www.zoetisdiagnostics.com
Reference
Bimeda has announced the launch of Bilovet, a new tylosin-based antibiotic for cattle and pigs.Padraig Hyland, Head of Technical Veterinary Services at Bimeda said: ''It is with great pleasure that I announce the launch of our much anticipated Bilovet 200 mg/ml solution for injection for cattle and pigs as the latest addition to Bimeda's range of essential antibiotics.
Bilovet contains Tylosin 200 mg/ml and is the second Tylosin-based injectable antibiotic to be licensed for cattle - including dairy cattle - in the UK. Bilovet is licensed in cattle for the treatment of respiratory infections, metritis, mastitis, interdigital necrobacillosis and calf diphtheria as well as a range of pig infections, including enzootic pneumonia, haemorrhagic enteritis, erysipelas, arthritis and metritis".
Bimeda's Head of Bimeda R+D, Xavier Molins said: "Bilovet is a completely new development for a product that includes a new species (cattle). Bimeda have made a significant investment in bringing Bilovet to market, including conducting new Environmental Risk Assessment studies according to current guidelines and regulations.''
For more information, ring 01248 725 400 or email: uksales@bimeda.com
The advice in the new help section has been designed to highlight the shared responsibilities of animal owners and their vet teams, and to support practices by giving this advice for pet owners in a clear and easy-to-read way.
It explains what pet owners can expect from their vet team - and what is expected of them - throughout the different stages of pet ownership.
The information is split into ten sections:
The content in the new resource was informed by the views of the RCVS’s Public Advisory Group (PAG), whose members comprise owners/keepers of companion animals, equine and production animals, as well as other users of veterinary services.
Veterinary surgeon and Chair of the RCVS PAG, Louise Allum MRCVS (pictured), said: "The PAG has performed an essential role in helping to inform the content creation for our animal owner help and advice resource, highlighting the need for greater transparency and support, particularly around veterinary fees, treatment options, and what to expect from vet practices.
"Veterinary professionals work tirelessly to provide the most appropriate care for their patients, and we want to support this by ensuring pet owners have access to clear, accessible information about their rights, responsibilities, and the role of veterinary teams to ensure that expectations are managed.
“We are calling upon veterinary professionals to share this resource with clients far and wide, to help owners understand more about veterinary practice and how they can build a successful partnership with their vet team, ultimately leading to better outcomes for pets, their owners and veterinary professionals alike."
The RCVS will be expanding its help and advice section to include further information for equine and livestock owners in due course.
www.rcvs.org.uk/owner-advice.
Next week, Princess Anne will unveil a new life-sized bronze of the Household Cavalry horse Sefton at the Royal Veterinary College in North Mymms, Hertfordshire.
The statue of Sefton is sited outside the College's Teaching and Research Centre, standing on the footprint of the former Sefton Equine Hospital, a facility which has now been relocated to a new Equine Referral Hospital on campus.
Sefton suffered terrible injuries in the Hyde Park bombing of July 1982 in which four men and seven horses died. In the aftermath of the bombing, as the most severely injured horse, his story of recovery captured the nation's hearts and the horse came to symbolise the resilience that is characteristic of the armed forces.
Many who knew and rode Sefton have provided the detailed briefings necessary for the sculptor, Camilla Le May, to capture the character and spirit of a great horse. Camilla said: "It was fascinating to talk to those who rode and knew Sefton well and this, along with studying old photos, enabled me to find out some of his individual traits such as the way he often tilted his head, looking back over his shoulder, which I chose to represent in this work. He was by all accounts a strong character and quite a handful, especially in his youth. Perhaps it was partly this strength of character that helped him pull through his appalling injuries."
Professor Josh Slater, head of the equine clinical group at the RVC, said: "The College has a proud tradition of furthering care and developing innovative treatments through dedicated equine veterinary surgeons and nurses. We were proud to have received a grant from The Horse Trust in 1986 to build our former equine hospital in Sefton's memory. Whilst we may have moved our practice to bigger and better facilities this new statue will serve as a reminder of the bravery and resilience of Sefton that inspired so many."
The new statue was commissioned to recognise and honour the life-time achievements of one of the College's longest servicing senior academics Professor Peter Lees, who retired in 2010. It was funded by RVC Honorary Fellow and Chairman of Norbrook Lord Ballyedmond OBE.
Professor Stuart Reid, Principal at the RVC, said: "I would like to thank the generosity of our friend Lord Ballyedmond for his kind donation in recognition of our esteemed colleague Professor Lees that has enabled us create this statue in memory of a great horse."
"Great Workplaces: Raising the Bar (Elevating Skills, Culture, and Leadership)" is a series of four in-depth conversations that will tackle themes that have an impact on recruitment and retention, uncovered through the Great Workplaces by BVA accreditation scheme.
All members of the profession are welcome to join the 50-minute webinar, which will be hosted by Rob Williams, BVA President, and Dr. Kirsten Ronngren, ManyPets Consulting Veterinarian & Vet Engagement Lead.
Rob said: “Effective mentorship is the backbone of any thriving veterinary workplace.
"Whether you’re guiding others or building your own skills, strong mentoring relationships can make all the difference.
"We hope colleagues find the webinars engaging and informative. In our first session, we’ll explore the power of mentoring and work through common gaps revealed by the Great Workplaces by BVA accreditation scheme.”
https://mybva.bva.co.uk/ems-event-calendar/mentoring-matters.html
The British Small Animal Veterinary Association has announced the appointment of Dr Frances Barr as Academic Director, tasked with developing the new BSAVA postgraduate qualification in association with the Open University, ready for launch in 2012.
Frances is a European Specialist in Veterinary Diagnostic Imaging, and a double diplomat of the Royal College of Veterinary Surgeons and the European College of Veterinary Diagnostic Imaging. She has worked both in practice and as an academic, with 26 years working in Higher Education, and has a long history of working as a BSAVA volunteer, eventually taking on the presidential mantle in 2007.
BSAVA says it aims to provide the best possible educational offering to the profession, particularly to those in practice. Grant Petrie, BSAVA President, said: "Producing a postgraduate qualification is a natural progression to BSAVA's current CPD offering - there is clearly a need for it and we have a strong legacy as a provider of quality CPD. We want to make sure that the profession is served well - with a programme designed by vets for vets. As a charity with education at the core of our remit, BSAVA is best positioned to create something that will keep investing in the knowledge and talent of the profession. However, we always knew that we would need an exceptional individual to oversee the programme, and, in Frances Barr, we know we have that person."
Frances said: "This will fill a really important need. Many practitioners have a real appetite for learning more about their particular area of interest. Of course, they can currently do this with general CPD courses, but this new qualification will provide a structured and focussed learning programme which is flexible enough to fit around the busiest lifestyle, yet challenging enough to make the qualification a personal achievement, one that will be well respected by the whole profession."
She added: "The proposed new certificates in small animal medicine and surgery will comprise a combination of traditional taught courses, a wide-range of web-based material that will include interactive sessions, and workplace-based projects. This is the way forward for practitioners and will lead the profession into a more secure future."
The qualifications will be aimed primarily at the general practitioner, so they are not designed to replace the European Diploma system or aspiring to provide specialised knowledge. Instead they will be created very much for the interested, busy practitioner for whom an accredited residency programme is not an option. Grant Petrie said: "Encouraging small animal practitioners to embark on a clinically useful, challenging yet achievable, highly regarded postgraduate qualification sits very well with the BSAVA's remit to promote excellence in small animal practice through education and science."
The BSAVA postgraduate programme will launch in 2012, with more information about registration available at Congress 2011 and online from April next year. Frances Barr will begin working with the Open University and the BSAVA team in November.
The RCVS Disciplinary Committee has dismissed a case against a London-based veterinary surgeon, having found charges related to fraudulent registration not proved.
Miss Maria Becerra Parga was charged with fraudulently entering her name on the Register of Veterinary Surgeons, by submitting a registration application in 2005 that contained a forged certificate of good standing from the Distinguished Official Veterinary Association of Lugo, Spain.
The Committee said that, in order to conclude Miss Becerra Parga had acted dishonestly, it needed to be sure that when she submitted the certificate to the RCVS she knew it was not genuine.
Miss Becerra Parga admitted that she did not make any application for the certificate directly to the Lugo Association. She accepted that the certificate she supplied to the College (the number of which was genuine and corresponded to a male veterinary surgeon registered in Spain) was a forgery, and that it contained a reference to her degree, a statement of good conduct, and was dated before she had a need for it; however, she said, this had been given to her by a friend and veterinary colleague and she had understood that she had been given a temporary membership of the Lugo Association for the purpose of registering with the RCVS. She also said that she had left these arrangements to her colleague and assumed that the document she had been given was genuine.
Her colleague, called as a witness by the College, said that Miss Becerra Parga had admitted the fraud to her and she denied that she had given the certificate to Miss Becerra Parga. Her friend said that she gave no more than general guidance because she knew that Miss Becerra Parga would be guided by a UK company that would arrange for her registration with the RCVS and through which she would be employed. She thought it possible that she had told Ms Becerra Parga that she needed a letter of recommendation, but she was not sure.
After careful consideration, the Committee preferred the evidence of Miss Becerra Parga and found her account to be "consistent with her naivety, inexperience and trusting nature" and "was sure that she did not forge the document herself". It found that to the extent that Miss Becerra Parga read the certificate at all when given it, she obviously did not notice its date or significance. The Committee was not able to say who was responsible for forging the certificate.
The Committee also dismissed an argument RCVS Counsel put forward, that Miss Becerra Parga had neither offered nor made payment for the certificate, and that she had forged the certificate to avoid a payment. The Committee said it did not find it credible that a veterinary surgeon, in work with a supportive family, who obviously was easily able to obtain proof of her good character directly from the university if necessary, would have jeopardised her entire career by forging the document, let alone for a small financial advantage.
The Committee directed that the charges be dismissed.
The RCVS has announced that it will start to accept the first applications for the new Advanced Practitioner status from the start of September.
The new accreditation status represents a 'middle tier' between veterinary surgeons holding an initial veterinary degree and RCVS Specialists and will demonstrate that the veterinary surgeon has advanced knowledge and experience in a designated field of veterinary practice.
Practising veterinary surgeons with at least five years' experience and a relevant postgraduate qualification are eligible to apply to be recognised as RCVS Advanced Practitioners. Accepted qualifications include the Certificate in Advanced Veterinary Practice (CertAVP) with a designation; the RCVS Certificate awarded up to 2012; postgraduate clinical qualifications awarded by universities or recognised awarding bodies; and other relevant clinical postgraduate master's degrees. Full details of eligible qualifications can be found at www.rcvs.org.uk/advanced
Advanced Practitioners will be expected to undertake at least 250 hours of continuing professional development (CPD) over each five-year period of accreditation, of which 125 hours should be in their designated field.
Dr Kit Sturgess is Chair of the Advanced Practitioner Assessors Panel and was involved in the development of the scheme. He said: "I am very proud that we will soon be accepting applications for the Advanced Practitioner status, just two years after the need for such an accreditation was highlighted by Professor Sir Kenneth Calman's Specialisation Working Party, set up to look at the whole specialisation framework.
"Being an Advanced Practitioner is more than just a status - it will demonstrate to members of the public and colleagues alike that a veterinary surgeon is working at an advanced level in their field and has made an ongoing commitment to career development and lifelong learning through engaging with CPD over and above the RCVS minimum requirement."
Applications from holders of the RCVS Certificate in Advanced Veterinary Practice (CertAVP) with a designation can apply from 1 September 2014 while those holding any other relevant qualifications can apply from 13 October 2014. The deadline for all applications during this first round is 30 November 2014.
Applications can be made online at www.rcvs.org.uk/advanced where further information about eligible qualifications, CPD requirements and other details can be found. The application fee for this year is £50 - from next year it will be £80. Thereafter there will be an annual fee to remain on the list (£80 by direct debit; £90 otherwise, at current rates).
All eligible applications will be assessed by the Advanced Practitioner Assessors Panel. The first list of Advanced Practitioners is due to be published, alongside the updated Specialist list, in spring 2015 subject to approval by the RCVS Education Committee in February 2015.
If accepted on to the list, practitioners will be able to use 'RCVS Advanced Practitioner in [designated field]' after their names. The accreditation and its designation will also be a primary search field on the RCVS Find a Vet practice database as well as appearing after an individual's name on the Check the Register search tool.
Once the first list has been published, the status of Advanced Practitioner will be promoted to the public.
A free webinar about Advanced Practitioner status, hosted by the Webinar Vet, will take place on Tuesday 30 September at 8.30pm. To register for the webinar visit www.thewebinarvet.com/rcvs-advanced-practitioner-status
For further advice or details about making an application for Advanced Practitioner accreditation, visit www.rcvs.org.uk/advanced or contact the Education Department on 020 7202 0791 or ap@rcvs.org.uk
The kit uses an indirect semi-quantitative IgG antibody assay which provides an easy-to-read colour change which clearly distinguishes normal IgG levels (>8mg/ml; colourless), partial FPT (4-8mg/ml; pink) and levels generally considered diagnostic of complete FPT (<4mg/ml; purple).
Vetlabs says the kit has a proven sensitivity and specificity of 97.4% and 93.6% respectively, and responds equally well with anticoagulant whole blood, serum or plasma. And with no additional equipment or refrigerated storage required, it is a true field test.
Mike Fleming, CEO of Vetlab Supplies Ltd said: "It’s not often you get to launch an equine diagnostic that’s genuinely life saving. With Fastest IgG Equine, vets can now give a clear-cut Failure of Passive Transfer (FPT) diagnosis at farms, stables or equestrian centres – and all in just 10 minutes."
According to the company, as many as 1 in 5 new-born foals can suffer some degree of IgG FPT. Foals with no antibody protection, due to complete FTP, have an estimated 75% chance of contracting debilitating or life-threatening infection. Even foals with some protection following partial FPT have only a 50% chance of resisting invaders such as Anaplasma, Giardia and Cryptosporidium.
The new-born foal’s absorption of maternal antibodies is most efficient in the first 6 to 8 hours of life, effectively ceasing after 24 to 36 hours. Veterinary surgeons and managers of equestrian facilities have only this narrow window to recognise FPT and act to save a valuable new-born from life threatening infection.
Mike added: "With Fastest Equine as part of their field kit, equine vets are equipped to diagnose and treat antibody deficient foals with life-saving colostrum, colsotrum formula substitute, or administer oral or intravenous IgG, within that critical first 24 hours."
Generally, veterinary practices may remain open, but there are national variations in what services should be offered and how, including the conditions under which remote prescribing can be used to help support a case.
Wales currently has the tightest ‘firebreak’ restrictions, meaning practices can only provide essential and urgent work until midnight on 8 November 2020, thereafter, returning to usual operations in line with Wales’ standard measures around workplace safety.
England and Northern Ireland are under national restrictions (4 Nov – 2 Dec, and 16 Oct – 12 Nov, respectively), meaning practices can provide treatment essential for maintaining animal health and welfare, along with non-urgent work providing that social distancing measures and safe working can be maintained.
Veterinary surgeons practising in these three countries may also choose to support a case remotely at an earlier stage, for example, through the remote prescribing of POM-Vs without first having conducted a physical examination.
Scotland remains the only country under regional tiered restrictions, meaning practices can continue to provide treatment whilst maintaining social distancing; however, before remote prescribing is offered, veterinary surgeons should first consider whether the animal can be brought under their care.
The full guidance and corresponding flowcharts should be consulted together and are available at www.rcvs.org.uk/covidfaq2and www.rcvs.org.uk/covidfaq4.
TwistPak bottles have a hygienic interlock at the bottom, which allows them to be connected with a twist, creating one single mixing chamber which fits in all standard vaccination devices.
Currently, freshly mixing two vaccines requires a transfer needle.
Boehringer says the TwistPak bottle simplifies the mixing process while retaining the flexibility of using the products as a monovalent or combined vaccine.
TwistPak was jointly created with the industrial design and product development company DESIGNquadrat and awarded a Red Dot Design Award 2021 in the product design category.
Eva Joras, Global Brand Manager at Boehringer Ingelheim said: “TwistPak revolutionizes how vaccines are mixed.
"The mixing platform combines the best of both worlds: the unparalleled quality and efficacy of freshly mixed vaccines with the convenience of ready-to-use solutions.
TwistPak will be globally available in all registered presentation sizes starting May this year.
Fort Dodge has unveiled an initiative to help practices improve peri-operative care and the management of hospitalised cases with the launch of its Early Warning Scoring System (EWSS) kit.
The kit contains cat and dog anaesthesia and observation charts for the effective monitoring of cats and dogs during operations, post-operatively and for hospitalised medical cases.
EWSS observation charts are widely used in the NHS but this is believed to be the first time that such a system has been developed specifically for use in veterinary practices.
They have been designed by Mike Davies BVetMed CertVR CertSAO FRCVS, Technical Services Manager at Fort Dodge, and are intended to help veterinary nurses and veterinary surgeons identify patients whose condition is deteriorating before they reach a critical state.
Mike Davies speaks around the country on preventive medicine and geriatrics and his experience of working closely with practices is that many do not have good protocols in place for nurse monitoring of patients. The EWSS grades parameters such as heart rate, respiratory rate, blood pressure and CNS response and the charts incorporate areas in which the practice can record pain using a visual analogue scale or a numeric scoring system.
The company has also launched Dorbene vet, a new product providing fast-acting sedation and analgesia for dogs and cats. Its active ingredient is the trusted and well proven alpha-2 agonist medetomidine hydrochloride, which affects the nervous system by inhibiting noradrenaline mediated neurotransmission. A dosing guide for Dorbene vet is also included in the EWSS.
The launch of Dorbene vet complements Fort Dodge's existing companion animal products, analgesic Torbugesic and dissociative anaesthetic Ketaset. Used alone it offers dose-related sedation within 10-15 minutes, which is rapidly reversible using the alpha-2 antagonist atipamezole for predictable recovery. It is presented in 10 ml and 50 ml multi dose vials in amber coloured glass which protects the product from light.
For further information on the EWSS or Dorbene vet, contact Fort Dodge on 01489 781711.
Virbac Animal Health has launched Speed Leish K, a diagnostic test for canine leishmaniosis.
Speed Leish K detects antibodies directed against the kinesins of leishmania using a Kinesin Capture Complex (KCC), a complex of recombinant proteins with strong immunogenic power at all stages of infection. Virbac says that in trials the test has demonstrated 98.5% overall accuracy.*
Virbac Product Manager Simon Boulton MRCVS said: "Leishmaniosis presents a growing threat to UK dogs, particularly those which travel with their owners on holiday to regions where the disease is endemic.
"Speed Leish K should be used as part of the primary CaniLeish vaccination protocol in animals previously at risk of exposure to ensure only health animals are vaccinated. The test can also be used to screen for the disease in animals suspected to be infected."
Speed Leish K is presented in kits of two or six tests and can be stored for 24 months at room temperature.
Elanco Companion Animal Health has announced that its Duvaxyn IE and IE-T Plus vaccines have been licensed for active immunisation against OIE recommended clade 1 and clade 2 equine influenza strains, the first vaccines to be so licensed.
The company says the updated license is a result of a recent challenge study which demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to induce cross protection against clade 2 strain A/equi-2/Richmond/1/07 (H3N8) two weeks after two doses of the primary course1 were given. Cross-protection was further supported by another study2 measuring serum antibody response to the Richmond '07 strain 52 weeks after the three dose primary vaccination course.
The OIE (World Organisation for Animal Health) updated its equine influenza vaccine recommendations in 2010 to reflect the fact that all field strains characterised through 2008 and 2009 were of clade 1 or 2 of the Florida sub-lineage. The antigenic difference between viruses of these clades could potentially compromise the effectiveness of vaccines containing a representative of a single clade3.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health UK, said: "Whilst no vaccine has been updated to match the current OIE recommendations, the results of our challenge study and subsequent licence update provide reassurance that horses vaccinated with Duvaxyn will be protected against clinical signs of disease caused by currently circulating strains of equine influenza, including those the OIE has identified as being of concern.
"Further reassurance is also given with the confirmation in our study that Duvaxyn IE-T Plus elicits a cell mediated immune response, recognised to play an important role to aid in viral clearance and further enhances protection against strains circulating in the field." 4
The live virus challenge study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two doses of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Richmond/1/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Duvaxyn IE-T Plus is the only inactivated whole virus carbomer adjuvanted equine influenza vaccine in the UK. According to Elanco, experts in the field of human vaccination have expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins including the conserved nucleoprotein, which shows no antigenic drift, in the vaccine5.
References
VetSurgeon.org has launched a new collaborative publishing section of the website (called a wiki) in which any member of the site may publish case studies and reports, abstracts, short communications, research papers and the results of clinical audit for open discussion and review by all.
The state-of-the-art systems in use on VetSurgeon then allow all members to comment on the work submitted. Initially, it's hoped that this will stimulate valuable further debate, discussion and critical review of papers that have already been published elsewhere. However, another benefit of this system is that it enables anyone in the profession to publish their research to the veterinary community immediately, without being at the mercy of such things as the availability of space in a traditional print journal, so original work is warmly welcomed.
Arlo Guthrie, editor of VetSurgeon said: "Of course I recognise that authors still want the kudos of publication in a traditional peer reviewed journal. However, in addition to offering immediate publication, this system also opens the review process up so that everyone in the profession can participate in a completely open way. If it works, it may even come to be thought of as a more stringent and robust method of review than the traditional method. Or perhaps more likely, peer review could become a two stage process in which work is assessed by a panel of experts and then by the sort of 'open review' offered by VetSurgeon.org."
Doubtless there will be concerns about the validity of information published in this new section of VetSurgeon, primarily because it may NOT have been subject to peer review at the time of publication. Arlo said: "I don't think this is an issue. VetSurgeon members should just have a different starting point. When you read content in, say Vet Record, you can presume it's been scrutinised and read it in that context. On VetSurgeon, you should assume the opposite, and then use the tools offered by the site to judge the value of the work yourself."
Ways of assessing work published on VetSurgeon.org include:
In phase one of this project, taking place over the coming few days, all abstracts published in Veterinary Practice magazine are being uploaded to the new wiki.
Click here to visit the new VetSurgeon Wiki
The RCVS Disciplinary Committee has accepted an application for restoration to the RCVS Register by Gordon Lonsdale, who had been struck off in March 2004 for illegally delegating acts of veterinary surgery to insufficiently qualified members of his practice staff.
At the initial Inquiry, Mr Lonsdale, who formerly worked as a sole practitioner in Shropshire, had admitted three separate charges of serious professional misconduct. These included allegations that he had instructed nurses and support staff to undertake dental extractions, dog and cat castrations, the removal of tumours or masses, the induction and maintenance of anaesthesia, lancing abscesses and suturing wounds.
At yesterday's hearing, the onus was on Mr Lonsdale to satisfy the Committee that he was fit to be restored to the Register, not least in view of his former health problems and the eight-year period for which he had been off the Register.
He provided the Committee with evidence of undertaking continuing professional development, including 130 hours of online courses and seven weeks of seeing practice, letters of endorsement from former clients and testimonials from friends and former colleagues.
The Committee accepted Mr Lonsdale's evidence that he had successfully addressed his alcoholism, which it recognised as being a contributory factor to his poor decision making in an isolated working environment. He assured the Committee of his intention that, should his application be successful, he intended to work only in a multi-handed, rather than single-handed, practice in future.
The Committee found him to be an honest and frank witness who had made a credible attempt to refresh his small animal practice knowledge; it was satisfied that he accepted the findings of the original hearing and that he had put the welfare of animals at risk, and it noted his expression of remorse.
In considering Mr Lonsdale's application, the Committee made a number of recommendations, including that he should register for the RCVS Professional Development Phase, undertake certain parts of the RCVS Certificate in Advanced Veterinary Practice, restrict himself to his recognised areas of competence, investigate communication courses run by the Veterinary Defence Society and continue with the mentoring programme provided by the Veterinary Surgeons Health Support Programme. Mr Lonsdale stated that he was willing to follow all of these recommendations.
Professor Peter Lees, who chaired and spoke on behalf of the Disciplinary Committee, concluded: "In these circumstances, we do not consider that any further period of erasure would be of benefit either to the public or the veterinary profession. Therefore, we direct the Registrar to restore Mr Lonsdale's name to the Register."
Woodley Equipment has launched ImmunoComb diganostic test kits for FIP, canine Leptospira and Ehrlichia
Woodley says the kits are easy to use and provide results within 20 minutes. No specialist laboratory equipment is required as the kits are self-contained with all the necessary reagents. The diagnostic kits determine the animal's antibody titre levels, in the case of the canine Ehrlichia as early as 7 days after infection, giving veterinary surgeons the opportunity to act more quickly in developing a prevention/treatment program.
Tests can be performed singly or up to 12 simultaneously.
For more information about ImmunoComb Diagnostic kits email sales@woodleyequipment.com or call: +44 (0) 1204 669033 Option 1. Alternatively visit http://www.woodleyequipment.com/
The results of the UK's first ever public National Equine Health Survey have quantified non-notifiable healthcare issues affecting horses, ponies, donkeys and mules in the UK.
The survey, which was pioneered by The Blue Cross animal charity and is supported by The British Equine Veterinary Association, was carried out last November following two years of pilot schemes. The intention was to find out more about endemic non-notifiable diseases that have never before been recorded in horses, ponies, donkeys and mules, such as coughs, skin diseases and lameness.
The results were announced at the National Equine Forum by Professor Josh Slater, Professor of Equine Clinical Studies at The Royal Veterinary College, who has been working with The Blue Cross on the survey.
A total of 306 sets of records were submitted from 3120 horses in mainly private ownership, with a balance of representation from competition yards, riding schools, welfare charities and studs. A broad range of syndromes and diseases were assessed including colic, sarcoids, laminitis, wounds, dental issues, eye disease, lameness and weight issues.
The results showed that lameness was the most common problem affecting horses (11% of horses surveyed) but that the foot was not the most common cause of lameness and that laminitis (3%) was less common than the 7-8% total that previous surveys had suggested.
Weight management was the next most common issue for horse owners, with 9% of horses recorded as overweight and 8% as underweight. These figures are lower than previous surveys which may be because they are based on the owner's assessment of their horse's weight which is subjective and may vary according to their perception of 'the right weight'.
Skin disease and wounds (5% and 4% respectively) posed a significant problem and colic (2%) was also a common occurrence, with a 6:1 ratio between medical and surgical cases.
The survey is breaking new ground in Europe as well as the UK. Currently Government agencies in all European countries conduct surveillance for prescribed exotic diseases such as West Nile Virus and African Horse Sickness but currently there are no large scale surveillance programmes for endemic diseases.
Professor Slater said: "The regular collection of such data holds numerous benefits to the UK equine industry. Not only does the survey provide a benchmarking facility for equine disease, welfare, standards of care and codes of practice but it will also underpin standards for yard inspection schemes. Not least it confirms the workability of an important template to monitor the serious threat of infectious and exotic disease in the future."
He added: "It's exciting to see hints in the NEHS 2010 survey that data 'straight from the horse's mouth' might challenge some established ideas. For example; the survey found that lameness was common, as you would expect, but that the foot was not the most common cause of lameness, which you might not have expected. This kind of data has never been collected before and is invaluable to the veterinary profession and wider animal welfare industry, helping to inform our future research, training and education. It will be really exciting to see the results of the larger surveys The Blue Cross are running in 2011."
Kerry Doyle, education officer at The Blue Cross said: "We are thrilled to be involved with this innovative project to enhance the future health of our horses and very grateful to all those who have participated in the survey so far. We now need even more horse owners to sign up for the next round so that we can capture as much useful data as possible."
The National Equine Health Survey is currently funded by The Blue Cross but sponsorship is being sought. It is to be conducted twice-yearly with the next census week planned for 9-15 May 2011. All keepers and owners of horses are urged to participate and details of all horse owners will remain anonymous. It's very quick and easy to complete and should only take around five minutes. To register online visit www.bluecross.org.uk/NEHS or email NEHS@bluecross.org.uk.
For the study, the RVC interviewed 13 small animal general practitioners, exploring their experience of providing pre-purchase consultations for brachycephalic dogs.
The study revealed a number of barriers to delivering effective pre-purchase consultations and advice about these breeds.
They included limited time and resources, competition for appointment availability, a perception that vets are only there to fix things, public distrust of veterinary surgeons (often over money), fear of damaging vet-client relationships, and the conflicting influence of breeders and the Kennel Club on clients.
Many veterinary surgeons that took part in the research felt that they had little or no power to overcome these barriers which are highly intractable at an individual veterinarian level.
A resulting moral conflict in veterinary surgeons between their perceived ethical and moral responsibilities to animal welfare versus the needs and wants of their clients and businesses was expressed by many vets in the study, and was felt to compromise their professional integrity and autonomy.
The study set out a series of recommendations:
Dr Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science at the RVC and lead author of the study, said: “This is the first time that the impact of brachycephaly on the practising veterinary surgeon has been explored.
"Our concerning results highlight the importance of recognising that the brachycephalic crisis is not only negatively impacting animals, but it is affecting human wellbeing too.
“Our study highlights the conflict that vets are experiencing - bound both by their duty of care to their brachycephalic patients, but also to animal welfare at a population level.
"Trying to balance both of these responsibilities in the current working environment is proving very challenging for some, leading to moral distress.
"It is, therefore, essential that we protect the mental wellbeing of vets on this issue as well as from an animal welfare perspective.
“As the brachycephalic crisis continues to prevail, the support of leading veterinary organisations is vital in providing a united voice regarding the known harms of brachycephaly and support in facilitating PPCs to ensure vets are protected, and potential owners are fully informed when it comes to acquiring decisions.”
Dr Dan O’Neill, Assoc Prof of Companion Animal Epidemiology at the RVC and co-author of the study, said:
“Over the past decade, the RVC has generated a vast evidence base revealing the true extent of the serious health issues of dogs with brachycephaly.
"This new study now focuses RVC research towards protecting the wellbeing of practising veterinary surgeons who are also shown as victims of the brachycephalic crisis.
"The clear message here is that we all need to ‘stop and think before buying a flat-faced dog’.”
Ceva Animal Health has launched PRID Delta, described as an improved intra-vaginal progesterone device for the synchronisation of oestrus in cycling and non-cycling cattle.
The company says it has used its 35 years of expertise in cattle fertility to develop PRID Delta, and that trials have demonstrated that the new device provides optimal progesterone release, preserved efficacy and high retention rates.
Ceva claims the special triangular shape and bi-material fabric of PRID Delta ensures maximum contact with vaginal mucosa to release optimal levels of progesterone at insertion and during treatment. The new PRID Delta continues to give a bigger progesterone peak after insertion as with the original PRID.
According to the company, clinical and field trials observing oestrus occurrence and fertility at fixed time artificial insemination have shown a preserved efficacy for PRID Delta. PRID Delta is licensed for oestrus synchronisation in both cycling and non cycling cows. It is licensed for fixed time AI. Trials have also confirmed that PRID Delta is quick and easy to insert, is well tolerated and has a retention rate of over 97%.
Ceva has recently introduced a new website www.reprology.com/ for technical advice on the best solutions for the management of cattle reproduction. For further information contact your Ceva sales representative or Ceva Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at www.ceva.uk.com/
Fabtek Solutions has announced the launch of Meditek, an activated carbon wound dressing which has been impregnated with silver to enhance its antibacterial qualities.
Joy Coutts from Fabtek Solutions said: "Meditek uses Zorflex which is a 100% pure activated carbon fibre. It has a huge surface area due to its microporous structure, and a permanent electrostatic charge that attracts bacteria towards it, where they are immobilised and retained. When removed from the substrate, the bacteria die, but the microscopic particulates of metallic silver accelerate the bacteria kill.
"Better still, Meditek carries no risk phases as it's non toxic and non invasive."
Joy added: "We are commercial members of the Vet Wound Library, an initiative designed to help promote modern wound care to veterinary professionals, it also means members can try our dressings for free."
According to Fabtek, Meditek has been tried and tested by vets and produced excellent results. The company's website also features some case studies which show the wound before and after the use of Meditek.
Dressings are available in 10cm x 10cm, and 15cm x 25cm sizes, which can be cut to fit. Prices start from £35 for a box of five.
For more information, see http://www.fabteksolutions.com/, email admin@fabteksolutions.com or call 07794094011.
Adam, who is one of only 17 ECC Specialists in the UK, will be developing an ECC service at Lumbry Park.
Following graduation and an internship at the Royal Veterinary College, Adam worked in hospital and emergency general practice. He completed his residency in Emergency and Critical Care in 2013 becoming board certified the same year. He also completed a Master’s in Veterinary Medicine at the Royal Veterinary College.
Adam became an RCVS Recognised Specialist in Emergency and Critical Care in 2015. In his most recent role, he was Group Head of Emergency and Intensive Care for four RCVS-Recognised hospitals and branches and oversaw standards of out-of-hours provision to 50+ sites. He also led the development of the first specialist 24-hour veterinary intensive care unit in central London.
Ray Girotti, Hospital Director, said: "Adam will be working with our multi-disciplinary team to offer a dedicated point of contact for emergency referrals, a move which will enhance the provision of critical care for our sickest patients. We are delighted to welcome a Specialist of his calibre to Lumbry Park."
Adam said: "The leadership on all issues relating to patient care shown by CVS’ Clinical Advisory Committee was inspiring and, with its full support, I have been offered an unrivalled opportunity to develop a leading ECC service at Lumbry Park. I’m really looking forward to my new role and to participating on the Clinical Advisory Committee to enhance ECC services right across CVS."
Defra's new measures include:
Eleven additional licences for badger control covering parts of Devon, Wiltshire, Somerset, Dorset and Cheshire. Licences have been granted for supplementary badger control in areas of Gloucestershire and Somerset which have completed their original four-year licences.
The relaunch of the Badger Edge Vaccination Scheme following suspension due to a global shortage of TB vaccine, with groups invited to submit expressions of interest and feedback on the criteria for the scheme.
A new bTB Advisory Service for farmers to provide advice on-farm and by phone or email to farmers in High Risk and Edge Areas on bTB biosecurity and risk-based trading, set to launch this autumn.
Tighter control of Inconclusive Reactors (IRs) in the High Risk and Edge Area, to come into force from 1 November.
British Veterinary Association (BVA) President Gudrun Ravetz said: "Today’s announcement sees 11 new licences issued and, while BVA supports badger culling as part of a comprehensive strategy for tackling bovine TB, we will continue to call on the Government to use the targeted and humane method of cage trapping and shooting only - rather than the current method of controlled shooting.
"As one of the many tools in the toolbox, we welcome the re-commencement of the Badger Edge Vaccination Scheme, particularly if used as a ‘firebreak’ to mitigate the spread of the disease into the low risk areas. The introduction of a TB Advisory Service will provide valuable additional support for farmers, who we’d encourage to continue working with local vets on biosecurity and herd health planning.
"Yet we are concerned that Government policy seems to have moved away from the original, evidence-based proposal of a six-week time limit for badger control within the open season, which enables an intensive, coordinated and effective operation in order to secure optimum disease control benefits.
"In terms of numbers, it is clear that badger population estimates have previously demonstrated considerable uncertainty and imprecision. It is critical that as accurate as possible population estimates, using an evidence-based methodology, are obtained and made openly available.
"We would urge clarity over cull timeframes, numbers and mid-cull review methodology to ensure that the progress made, enabling the application for Officially TB Free status, is not undermined."
Today’s Defra update follows a consultation on licensed badger control conducted at the start of 2017, to which the British Veterinary Association (BVA), British Veterinary Zoological Society (BVZS) and the Association of Government Veterinarians (AGV) submitted a formal, joint response.
Photo: Young Eurasian Badger (Meles Meles), by BadgerHero, CC BY-SA 3.0